Aisha Taylor, MD
Urogynecology and Reconstructive Pelvic Surgery · Hanover, MDNPI 1336467414
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $19,000 of the $29,274 with a category attached, or 64.9%. Axonics, Inc. accounts for 93.5% of it on its own, with 28 other manufacturers making up the rest. Reporting peaked in 2021 at $18,947 and has fallen 99.3% since, to $130 in 2025.
Across 169 payments — averaging $173.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axonics, Inc.$27K
- Johnson & Johnson$261
- AbbVie$225
- Endo Pharmaceuticals Inc.$177
- Urovant Sciences Inc$128
- Boston Scientific$123
- plus $995 from 23 others
Across 167 payments — averaging $446.26 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Axonics, Inc.$75K
What the payments were for
- Consulting fees$19,00065%
- Speaking & faculty fees$1160%
- Travel & lodging$7,13124%
- Food & beverage$3,02810%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axonics, Inc. | 78 | $27,365 |
| Johnson & Johnson | 14 | $261 |
| AbbVie(2 entities) | 9 | $225 |
| Endo Pharmaceuticals Inc. | 7 | $177 |
| Urovant Sciences Inc | 8 | $128 |
| Boston Scientific | 7 | $123 |
| Caldera Medical, Inc | 1 | $117 |
| Astellas Pharma US Inc | 6 | $112 |
| Antares Pharma, Inc. | 7 | $111 |
| Tolmar Pharmaceuticals, Inc. | 4 | $95 |
| Dendreon Pharmaceuticals LLC | 3 | $76 |
| Merck | 3 | $52 |
| Myriad Genetic Laboratories, Inc. | 3 | $44 |
| Alnylam Pharmaceuticals Inc. | 2 | $44 |
| Janssen Scientific Affairs, LLC | 1 | $37 |
| Applied Medical Resources Corporation | 1 | $32 |
| 180 Medical, Inc. | 1 | $28 |
| Neotract Inc. | 2 | $27 |
| Convatec Inc. | 1 | $27 |
| Amgen | 2 | $26 |
| Valencia Technologies Corporation | 1 | $26 |
| Contura, Inc. | 1 | $24 |
| Travere Therapeutics, Inc. | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Blue Earth Diagnostics | 1 | $17 |
| Photocure Inc | 1 | $16 |
| Femselect Inc. | 1 | $15 |
| Angiodynamics, Inc. | 1 | $14 |
| Pfizer | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Axonics r-SNM System$17,831
- Axonics$8,299
- Bulkamid$5,822
- Desara$117
How this compares
Too few urogynecology and reconstructive pelvic surgery providers in Marylandto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other urogynecology and reconstructive pelvic surgery in Hanover
- Mava Robinson-WaltonSilver Spring$257K
- Daniel GruberBethesda$91K
- Anita Pillai AllenSilver Spring$38K
- Robert GutmanBaltimore$28K
- Yong ZhengBowie$14K
- Heather BarbierBethesda$10K
- Kay HoskeyAnnapolis$9K
- Richard EllerkmannLutherville$7K
- Christine VaccaroBethesda$7K
- Shobha SikkaChevy Chase$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.